350 related articles for article (PubMed ID: 30524939)
1. Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies.
Xia G; Terada N; Ashizawa T
Curr Stem Cell Rep; 2018; 4(4):299-309. PubMed ID: 30524939
[TBL] [Abstract][Full Text] [Related]
2. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
Elife; 2022 Jan; 11():. PubMed ID: 35076017
[TBL] [Abstract][Full Text] [Related]
3. Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
Kalra S; Montanaro F; Denning C
J Neuromuscul Dis; 2016 Aug; 3(3):309-332. PubMed ID: 27854224
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.
Mohamadian M; Rastegar M; Pasamanesh N; Ghadiri A; Ghandil P; Naseri M
J Mol Neurosci; 2022 Jan; 72(1):9-23. PubMed ID: 34727324
[TBL] [Abstract][Full Text] [Related]
6. iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies.
Ortiz-Vitali JL; Darabi R
Cells; 2019 Jan; 8(1):. PubMed ID: 30609814
[TBL] [Abstract][Full Text] [Related]
7. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
8. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
Abujarour R; Bennett M; Valamehr B; Lee TT; Robinson M; Robbins D; Le T; Lai K; Flynn P
Stem Cells Transl Med; 2014 Feb; 3(2):149-60. PubMed ID: 24396035
[TBL] [Abstract][Full Text] [Related]
9. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
10. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.
Tedesco FS; Gerli MF; Perani L; Benedetti S; Ungaro F; Cassano M; Antonini S; Tagliafico E; Artusi V; Longa E; Tonlorenzi R; Ragazzi M; Calderazzi G; Hoshiya H; Cappellari O; Mora M; Schoser B; Schneiderat P; Oshimura M; Bottinelli R; Sampaolesi M; Torrente Y; Broccoli V; Cossu G
Sci Transl Med; 2012 Jun; 4(140):140ra89. PubMed ID: 22745439
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies.
Piga D; Salani S; Magri F; Brusa R; Mauri E; Comi GP; Bresolin N; Corti S
Ther Adv Neurol Disord; 2019; 12():1756286419833478. PubMed ID: 31105767
[TBL] [Abstract][Full Text] [Related]
13. Gene correction in patient-specific iPSCs for therapy development and disease modeling.
Jang YY; Ye Z
Hum Genet; 2016 Sep; 135(9):1041-58. PubMed ID: 27256364
[TBL] [Abstract][Full Text] [Related]
14. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.
Kunkel LM; Bachrach E; Bennett RR; Guyon J; Steffen L
J Hum Genet; 2006; 51(5):397-406. PubMed ID: 16583129
[TBL] [Abstract][Full Text] [Related]
16. Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem Cells.
Mazaleyrat K; Badja C; Broucqsault N; Chevalier R; Laberthonnière C; Dion C; Baldasseroni L; El-Yazidi C; Thomas M; Bachelier R; Altié A; Nguyen K; Lévy N; Robin JD; Magdinier F
Cells; 2020 Jun; 9(6):. PubMed ID: 32585982
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
18. Patient-specific iPSC-derived cellular models of LGMDR1.
Mateos-Aierdi AJ; Dehesa-Etxebeste M; Goicoechea M; Aiastui A; Richaud-Patin Y; Jiménez-Delgado S; Raya A; Naldaiz-Gastesi N; López de Munain A
Stem Cell Res; 2021 May; 53():102333. PubMed ID: 33862537
[TBL] [Abstract][Full Text] [Related]
19. Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.
Gee P; Xu H; Hotta A
Stem Cells Int; 2017; 2017():8765154. PubMed ID: 28607562
[TBL] [Abstract][Full Text] [Related]
20. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
Srivastava NK; Annarao S; Sinha N
Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
